Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
34,874
Total Claims
$1.3M
Drug Cost
1,686
Beneficiaries
$749
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-51%
Cost per patient vs peers
$749 vs $1,524 avg
-49%
Brand preference vs peers
7.0% vs 13.7% avg
Brand vs Generic
Brand: 2,443 claims · $881K
Generic: 32,431 claims · $382K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 357 | $224K |
| Dapagliflozin Propanediol | 323 | $199K |
| Rivaroxaban | 315 | $196K |
| Empagliflozin | 93 | $64K |
| Evolocumab | 80 | $47K |
| Candesartan Cilexetil | 447 | $42K |
| Ticagrelor | 84 | $41K |
| Losartan Potassium | 2,740 | $29K |
| Doxazosin Mesylate | 2,343 | $27K |
| Sacubitril/Valsartan | 37 | $23K |
| Metoprolol Succinate | 1,664 | $22K |
| Atorvastatin Calcium | 2,781 | $22K |
| Rosuvastatin Calcium | 2,649 | $20K |
| Candesartan/Hydrochlorothiazid | 154 | $19K |
| Ezetimibe | 1,222 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
2.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data